» Articles » PMID: 2003120

Correlates of Fatigue in People with Breast or Lung Cancer

Overview
Specialties Nursing
Oncology
Date 1991 Jan 1
PMID 2003120
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Fatigue is regarded as a universal and unavoidable side effect of cancer therapy, yet its epidemiology and prevalence in populations of people with cancer have not been well-documented. Using the conceptual framework of Piper, et al., this study examined and described the perception and manifestations of fatigue and its physiological, biochemical, and behavioral correlates. A convenience sample (N = 77) of people with lung (n = 33) or breast cancer (n = 44) completed several instruments: a brief questionnaire, the Rhoten Fatigue Scale, a visual analogue scale (VAS), the Rhoten Fatigue Checklist, and the shortened version of the Profile of Mood States (POMS). Data on other factors thought to influence fatigue were collected via medical record audit. Seventy-five of 76 people (99%) completing the VAS experienced some level of fatigue. Significant correlates of fatigue included level of pain and POMS scores. Preliminary findings suggest that fatigue is a common problem with a complex etiology and that nurses must consider potential contributing factors when assessing fatigue and its impact on the individual.

Citing Articles

Associations between Symptoms and Exercise Barriers in Breast Cancer Survivors.

Scott H, Brown N, Schleicher E, Oster R, McAuley E, Courneya K J Clin Med. 2023; 12(20).

PMID: 37892669 PMC: 10607025. DOI: 10.3390/jcm12206531.


Hypnosis and cognitive behavioral therapy with online sessions to reduce fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: Rational and study protocol for a feasibility study.

Baussard L, Cousson-Gelie F, Jarlier M, Charbonnier E, Le Vigouroux S, Montalescot L Front Psychol. 2022; 13:953711.

PMID: 35967617 PMC: 9363840. DOI: 10.3389/fpsyg.2022.953711.


Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.

Wilson H, Stanton D, Rellick S, Geldenhuys W, Pistilli E Am J Physiol Cell Physiol. 2021; 320(4):C577-C590.

PMID: 33439777 PMC: 8260354. DOI: 10.1152/ajpcell.00264.2020.


Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.

Wilson H, Rhodes K, Rodriguez D, Chahal I, Stanton D, Bohlen J Clin Cancer Res. 2018; 25(7):2336-2347.

PMID: 30559167 PMC: 6445680. DOI: 10.1158/1078-0432.CCR-18-1565.


Clinical significance of cancer-related fatigue in multiple myeloma patients.

Suzuki K, Kobayashi N, Ogasawara Y, Shimada T, Yahagi Y, Sugiyama K Int J Hematol. 2018; 108(6):580-587.

PMID: 30155589 DOI: 10.1007/s12185-018-2516-1.